VIS Stock UPDATES Industrials ETF Vanguard (VIS) 104.01 09/17/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Industrials ETF Vanguard (VIS) 104.01 $VIS

Industrial Stock Earnings Fail to Impress These ETFs - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Mon Jul 28, 7:00AM CDT
Industrial stocks like Caterpillar, General Electric and Honeywell reported earnings putting industrial ETFs in focus.

VIS, DHR, EMR, PCP: Large Outflows Detected at ETF
ETFChannel.com - Wed Jun 25, 10:21AM CDT
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the Vanguard Industrials ETF where we have detected an approximate $20.8 million dollar outflow -- that's a 1.1% decrease...

New American Industrial Renaissance ETF Hits the Market - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Wed Mar 19, 7:00AM CDT
For investors seeking a new type of industrial ETF, consider this fund focusing on the American industrial renaissance from First Trust.

Apache Announces Executive Changes
PR Newswire - Fri Feb 14, 11:52AM CST
Apache Corporation (NYSE, Nasdaq: APA) announced today several changes to its executive organization:

Industrial ETFs in Focus on Lukewarm GE Earnings - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Mon Jan 20, 1:03PM CST
These industrial ETFs could be in focus following GE's earnings beat and profit miss.

3 ETFs for Manufacturing "Renaissance" - ETF News And Commentary
Neena Mishra - Zacks Investment Research - Tue Aug 06, 7:18AM CDT
Low energy prices, improving technology and stagnant wages could result in a strong manufacturing rebound in the US.

3 Industrial ETFs to Buy After Solid GE Earnings - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Mon Jul 22, 9:30AM CDT
After GE's solid figures, it may be time to buy these industrial ETFs.

3 ETFs To Watch This Week: 4/12
Daniela Pylypczak - ETFDB - Mon Apr 15, 3:00AM CDT
Bullish momentum somewhat returned on Wall Street last week, pushing major U.S. stock indexes into uncharted territory once again. Investors welcomed an encouraging labor report, which showed that initial jobless claims fell more than expected, to...

SVNT, UTIW, USMO, MOLXA, GLNG, VIS Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Thu Mar 28, 6:00AM CDT
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Savient Pharmaceuticals Inc (NASDAQ:SVNT), UTI WORLDWIDE INC (NASDAQ:UTIW), USA Mobility Inc (NASDAQ:USMO), Molex Inc (NASDAQ:MOLXA), Kontsern Halnaftohaz PAT (NASDAQ:GLNG), Vanguard Industrials Etf (NYSE:VIS) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

FDS, UFPT, VIS, OTTR, SSI, WDFC Are Seasonally Ripe To Go Up In the Next Five Weeks
M2 - Thu Feb 21, 5:49AM CST
BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of FactSet Research Systems Inc (NYSE:FDS), UFP TECHNOLOGIES, INC. (NASDAQ:UFPT), Vanguard Industrials Etf (NYSE:VIS), Otter Tail Corp (NASDAQ:OTTR), STAGE STORES, INC. (NYSE:SSI), WD-40 Co (NASDAQ:WDFC) and each have a high seasonal probability to go Up in the next weeks. By identifying stocks that are poised to go up or down based on seasonal tendencies, traders can increase their odds of making money. SqueezeTrigger.com is able to analyze over 20 years of data in less than 1 second for any stock in the market and determine if the stock has a long or short seasonal bias, how many trading days the move is expected to last, the probability of that move and the percentage move the stock is expected to make based on the seasonal bias. The technology used to generate these predictions is available for a low monthly fee at:

Daily ETF Roundup: Stocks End Mixed
Daniela Pylypczak - ETFDB - Wed Feb 13, 5:07PM CST
Strong pullbacks in several bellwether stocks had markets struggling for a definitive direction today, with the bulls and bears seemingly reaching a stalemate amidst a lack of significant market catalysts. Meanwhile, investors attempted to digest...

The State of the Union Address for Investors - Analyst Blog
John Blank - Zacks Investment Research - Wed Feb 13, 2:21PM CST
Here is my short-form take on President Obama's State of the Union address. This is written to outline four major areas that concern stock market investors.

A Technical Take on Industrial ETFs with ISM Data Release - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Wed Jan 02, 1:00PM CST
Should investors look to XLI with key ISM data on tap?

Vanguard Cuts Expenses on 22 ETFs
ETFguide.com - ETFG - Fri Dec 28, 7:27PM CST
Vanguard, the largest U.S. mutual fund provider, has reduced the annual expense ratios on 22 ETFs. The fee cuts will affect 10 industry sector funds, eight bond funds, and four broad equity funds.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 232

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Ambrosia Biosciences Unveils Promising Nonclinical Metabolic Data

Updated Category News Views 136

Ambrosia's Latest Nonclinical Revelations Ambrosia Biosciences has just thrown out some major bait at ObesityWeek® 2026. The highlight? New nonclinical data profiles for two of their understudy small molecule programs—AMB-895 and AMB-131. It may sound niche, but in this sector, promising data spins heads. Their GLP-1 receptor agonist, AMB-895, and GIP receptor...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 104

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 373

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 103

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 0

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 49

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 133

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 38

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 135

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading

Top 5 Most Recently Viewed Articles

Cassava Sciences Takes Strategic Steps Amid Clinical Developments

Updated Category News Views 241

Cassava Sciences Provides Key Business Update Cassava Sciences, Inc. (NASDAQ: SAVA), a biotechnology company dedicated to developing innovative treatments for central nervous system disorders, has shared an important business update that affects both its operations and strategic direction. Important Study Results and Future Plans Recent data from the Phase 3 RETHINK-ALZ...

Continue Reading
ColdVentures Welcomes Dr. Barrak Alahmad as Strategic Advisor

Updated Category News Views 164

ColdVentures Expands Leadership with Key Appointment ColdVentures, a pioneering medical device company focused on addressing heat-related illnesses, has taken a significant step forward by appointing Dr. Barrak Alahmad as a strategic advisor. Dr. Alahmad, known for his expertise in environmental health and climate change, brings a wealth of knowledge to the role,...

Continue Reading
Season Group Hits Top 15% with EcoVadis Silver Medal

Updated Category News Views 40

Season Group's Silver Medal Moment Well, it's not every day that a company gets a pat on the back for actually doing something good, but that's what you have here with Season Group snagging the EcoVadis Silver Medal. It’s like the Oscars for sustainability, and it puts them in the top 15% of companies assessed globally by these sustainability gurus. That’s a title...

Continue Reading
LSPedia Achieves Notable Recognition in Business Category

Updated Category News Views 144

LSPedia Celebrated for Excellence in Business LSPedia is thrilled to announce its recent inclusion in Inc.'s 2024 Best in Business list, specifically in the Software as a Service category. This prestigious recognition highlights organizations that are industry leaders and stand out for their impactful achievements. A Testament to Industry Leadership In recognizing...

Continue Reading
Bev Colan Appointed as President of Venn Workforce Optimization

Updated Category News Views 216

Venn Workforce Optimization Welcomes New Leadership In an exciting development for Venn Workforce Optimization, Bev Colan has been named the company president. This marks a significant step for the organization, which specializes in locum tenens optimization and workforce solutions technology. Bev Colan: A Proven Leader Bev Colan joins the Venn team with over 20 years of...

Continue Reading